全文获取类型
收费全文 | 971篇 |
免费 | 95篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 79篇 |
妇产科学 | 16篇 |
基础医学 | 156篇 |
口腔科学 | 22篇 |
临床医学 | 88篇 |
内科学 | 192篇 |
皮肤病学 | 7篇 |
神经病学 | 92篇 |
特种医学 | 40篇 |
外科学 | 85篇 |
综合类 | 13篇 |
预防医学 | 75篇 |
眼科学 | 47篇 |
药学 | 60篇 |
肿瘤学 | 72篇 |
出版年
2023年 | 12篇 |
2021年 | 24篇 |
2020年 | 10篇 |
2019年 | 31篇 |
2018年 | 31篇 |
2017年 | 17篇 |
2016年 | 23篇 |
2015年 | 33篇 |
2014年 | 28篇 |
2013年 | 35篇 |
2012年 | 54篇 |
2011年 | 52篇 |
2010年 | 41篇 |
2009年 | 27篇 |
2008年 | 48篇 |
2007年 | 45篇 |
2006年 | 56篇 |
2005年 | 37篇 |
2004年 | 36篇 |
2003年 | 43篇 |
2002年 | 47篇 |
2001年 | 22篇 |
2000年 | 20篇 |
1999年 | 6篇 |
1997年 | 8篇 |
1995年 | 9篇 |
1992年 | 15篇 |
1991年 | 18篇 |
1990年 | 21篇 |
1989年 | 22篇 |
1988年 | 22篇 |
1987年 | 18篇 |
1986年 | 9篇 |
1985年 | 8篇 |
1984年 | 10篇 |
1983年 | 9篇 |
1982年 | 8篇 |
1981年 | 10篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 7篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 5篇 |
1970年 | 6篇 |
1969年 | 5篇 |
1966年 | 4篇 |
排序方式: 共有1069条查询结果,搜索用时 343 毫秒
1.
Shannon Gravely James F. Thrasher K. Michael Cummings Janine Ouimet Ann McNeill Gang Meng Eric N. Lindblom Ruth Loewen Richard J. OConnor Mary E. Thompson Sara C. Hitchman David Hammond Bryan W. Heckman Ron Borland Hua‐Hie Yong Tara Elton‐Marshall Maansi Bansal‐Travers Coral Gartner Geoffrey T. Fong 《Addiction (Abingdon, England)》2019,114(Z1):71-85
2.
3.
More than just crushing: a prospective pre‐post intervention study to reduce drug preparation errors in patients with feeding tubes 下载免费PDF全文
4.
Kishor Devalaraja-Narashimha Karoline Meagher Yifan Luo Cong Huang Theodore Kaplan Anantharaman Muthuswamy Gabor Halasz Sarah Casanova John OBrien Rebecca Peyser Boiarsky John McWhirter Hans Gartner Yu Bai Scott MacDonnell Chien Liu Ying Hu Adrianna Latuszek Yi Wei Srinivasa Prasad Tammy Huang George Yancopoulos Andrew Murphy William Olson Brian Zambrowicz Lynn Macdonald Lori G. Morton 《Journal of the American Society of Nephrology : JASN》2021,32(1):99
5.
Coral Parikh Victoria Gutgarts Elliot Eisenberg Michal L. Melamed 《Seminars in dialysis》2015,28(6):604-609
Most dialysis patients are vitamin D deficient, including deficiencies in both activated vitamin D (1, 25‐dihydroxyvitamin D) and the less active 25‐hydroxyvitamin D. These and other abnormalities associated with chronic kidney disease (CKD), if they remain untreated, lead to secondary hyperparathyroidism and bone changes, such as osteitis fibrosa cystica. Activated vitamin D has been proven to decrease parathyroid hormone (PTH) levels in dialysis patients and is currently used for this indication. There are multiple other potential “pleotrophic” effects associated with vitamin D therapy. These include associations with lower all‐cause and cardiovascular mortality, lower rates of infections and improved glycemic indexes. Meta‐analyses of multiple observational studies have shown activated vitamin D therapy to be associated with improved survival. Observational data also suggest fewer infections and better glucose control. There have been no randomized clinical trials powered to evaluate mortality or other clinical outcomes. Small trials of nutritional vitamin D (ergocalciferol and cholecalciferol) showed increases in 25‐hydroxyvitamin D levels without hypercalcemia or hyperphosphatemia, even when given in addition to activated vitamin D therapy. While activated vitamin D therapy is associated with improved outcomes, it also leads to higher fibroblast growth factor 23 (FGF‐23) levels, which may be detrimental in dialysis patients. Further research is needed to evaluate whether activated or nutritional vitamin D therapy are beneficial in dialysis patients for outcomes other than secondary hyperparathyroidism. 相似文献
6.
7.
8.
9.
10.
Coral Bravo MD PhD Francisco Gámez MD PhD Ricardo Pérez MD PhD Teresa Álvarez MD Juan De León-Luis MD PhD 《Journal of ultrasound in medicine》2016,35(2):237-251
Aortic arch anomalies are present in 1% to 2% of the general population and are commonly associated with congenital heart disease, chromosomal defects, and tracheaesophageal compression in postnatal life. The sonographically based detection of aortic arch anomalies lies in the 3‐vessel and trachea view. Although highly sensitive, this view alone does not allow identification of the aortic arch branching pattern, which prevents an accurate diagnosis. The systematic addition of a subclavian artery view as part of a standardized procedure may be useful in the differential diagnosis of these conditions. We describe the sonographic assessment of fetal aortic arch anomalies by combining 2 fetal transverse views: the 3‐vessel and trachea view and the subclavian artery view, which are included in the cardiovascular system sonographic evaluation protocol. We also review the sonographic findings and the clinical implications of fetal aortic arch anomalies. 相似文献